NCCN Guidelines® Insights: Breast Cancer, Version 4.2023
Robert H. Lurie Comprehensive Cancer Center of Northwestern University · Yale Cancer Center · +45 more institutions
Abstract
The NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines) for Breast Cancer address all aspects of management for breast cancer. The treatment landscape of metastatic breast cancer is evolving constantly. The therapeutic strategy takes into consideration tumor biology, biomarkers, and other clinical factors. Due to the growing number of treatment options, if one option fails, there is usually another line of therapy available, providing meaningful improvements in survival. This NCCN Guidelines Insights report focuses on recent updates specific to systemic therapy recommendations for patients with stage IV (M1) disease.
Citation impact
- FWCI
- 92.05
- Percentile
- 100%
- References
- 44
Authors
37- WJWilliam J. GradisharCorresponding
Robert H. Lurie Comprehensive Cancer Center of Northwestern University
- MSMeena S. Moran
Yale Cancer Center, Smilow Cancer Hospital
- JAJame Abraham
Cleveland Clinic, Cancer Institute (WIA), University Hospitals Seidman Cancer Center
- VGVandana G. Abramson
Breast Cancer Research Foundation, Vanderbilt-Ingram Cancer Center
- RARebecca Aft
Barnes-Jewish Hospital, Jewish Hospital
Topics & keywords
- Medicine
- Breast cancer
- Clinical Practice
- Systemic therapy
- Metastatic breast cancer
- Intensive care medicine
- Oncology
- Disease
- Good health and well-being